Human norovirus (hNoV) infectivity was studied using a three-dimensional model of large intestinal epithelium. Large intestine Caco-2 cells were grown in rotating wall vessel bioreactors for 18-21 days at 371C and then transferred to 24-well tissue culture plates where they were infected with GI.1 and GII.4 human noroviruses collected from human challenge trials and various outbreak settings, respectively. Compared with uninfected cells, transmission micrographs of norovirus-infected cells displayed evidence of shortening or total loss of apical microvilli, and vacuolization. Quantitative reverse transcription real-time PCR (qRT-PCR) indicated an approximate 2-3 log 10 increase in viral RNA copies for the infected cells. A passage experiment examined both the ability for continued viral RNA and viral antigen detection. In the passaged samples 1.01 Â 10 6 copies ml À1 were detected by qRT-PCR. Immune electron microscopy using primary antibody to hNoV GI.1 capsids in conjunction with 6 nm gold-labelled secondary antibodies was performed on crude cellular lysates. Localization of antibody was observed in infected but not for uninfected cells. Our present findings, coupled with earlier work with the three-dimensional small intestinal INT407 model, demonstrate the utility of 3-D cell culture methods to develop infectivity assays for enteric viruses that do not readily infect mammalian cell cultures.
INTRODUCTION
Human noroviruses (hNoV) are the leading cause of nonbacterial gastroenteritis worldwide. In the United States alone, it is estimated that 23 million people per year become infected (Centers for Disease Control and Prevention (US) 2007). Typically, exposed individuals exhibit severe gastrointestinal symptoms within 12-24 h of exposure, and symptoms last from 24 to 72 h after onset of symptoms. Peak viral shedding in faeces averages 11 days post-infection, and infected individuals may continue to excrete virus for greater than 30 days (Atmar et al. 2008) . Normally, there are no chronic complications due to infection by noroviruses.
Nevertheless, for some compromised individuals, persistent gastrointestinal disease, isolation of the virus in cerebrospinal fluid in an encephalitis patient, and even death can occur (Karst 2010) . With the significant number of publicly reported norovirus outbreaks in 2006 (Centers for Disease Control & Prevention (US) 2007), questions regarding their evolution (Frankhauser et al. 2002) , and what these changes may bring in terms of increased virulence and possible mortality are raised. It is apparent that proactive study is required to determine what physical control measures are needed to mitigate or prevent subsequent outbreaks.
The difficulties with studying the human noroviruses in vitro have been well documented. Consistent infection and replication of these viruses in vitro has not been demonstrated to any great extent (Duizer et al. 2004; Straub et al. 2007; Lay et al. 2010) . Duizer et al. (2004) investigated a number of human and animal cell lines, methods for differentiation and various treatments to find a cell line and conditions that would support replication, but was unsuccessful. Straub et al. (2007) (Wobus et al. 2004 (Wobus et al. , 2006 .
Several studies have demonstrated the utility of growing cells as three-dimensional tissues for studying pathogenesis of other infectious diseases including enteric pathogens (Long et al. 1999; Long & Hughes 2001; Nickerson et al. 2001 Nickerson et al. , 2005 Nickerson & Ott 2004; Carterson et al. 2005; Carvalho et al. 2005; Lamarca et al. 2005 ; Honer zu Bentrup et al. 2006) . In the case of the 3-D small intestinal (INT 407) epithelial model for human norovirus infectivity, well-formed apical microvilli are expressed and these may serve as the initial site of hNoV attachment (Straub et al. 2007 ). Microvilli are not well expressed in conventional two-dimensional (2-D) monolayers for either small or large intestinal epithelial models (Nickerson et al. 2001 ; Honer zu Bentrup et al. 2006 ) and this key factor of cellular differentiation could be a potential factor that explains why 2-D cultures have been largely unsuccessful for developing an infectivity assay for human noroviruses.
We sought to improve the reproducibility of the human norovirus infectivity assay that we had previously developed using the 3-D INT 407 cell line (Straub et al. 2007 ) by investigating an alternative cell line grown as a dynamic three-dimensional tissue culture. Despite being a heterogeneous cell line with multiple normal and cancer cellular phenotypes, we chose Caco-2 cells based on the following observations. Grown longer term (42 weeks) as threedimensional trans-well membrane cultures, some cellular phenotypes differentiate to produce apical brush borders characteristic of normal small and large intestines (Peterson & Mooseker 1992) . Histoblood group antigens on epithelial cell surfaces and mucosal secretions, produced by a functioning a (1,2) fucosyltransferase (FUT2) enzyme (e.g. positive secretor status), have been hypothesized as receptors for hNoV, and Caco-2 has been demonstrated to have these receptors (White et al. 1996; Harrington et al. 2002 Harrington et al. , 2004 Hutson et al. 2003; Marionneau et al. 2002) . In addition, White et al. (1996) demonstrated that norovirus-like particles were internalized in Caco-2 cells grown as traditional 2-D cell cultures. Thus, the aim of our study was to determine if Caco-2, grown as a dynamic three-dimensional cell culture, could differentiate into cells expressing brush borders, and if these differentiated cells could support infection by Genogroup I and Genogroup II noroviruses. Approximately 250 mg of Cytodex-3 porous collagen-I coated microcarrier beads (Sigma) were washed three times in 1X Hanks Balanced Salt Solution without calcium and magnesium (HBSS, Sigma). On the final wash the HBSS was aspirated to approximately 1 ml above the bead suspension, and then transferred to a 55 ml reusable slow turning lateral vessel bioreactor (Synthecon, Houston, TX) fitted with 5 and 10 ml leur-lock type syringes. The hydrated bead suspension volume was approximately 2.5 ml. Cells were then transferred to the bioreactor and incubated in a 371C, 5% CO 2 incubator without rotation for 1 hour to allow cells to attach to the microcarrier beads. Media was then added to the bioreactor through the 5 and 10 ml syringes until the bioreactor was full, and the 5 ml syringe was nearly filled with media. Air bubbles in the bioreactor were expelled through the 5 and 10 ml syringes. When free of bubbles, the stopcocks between the syringes and bioreactors were closed and the bioreactor was attached to the base and the rotation speed was set at 18 RPM. The bioreactor was inspected daily for air bubbles, and if detected, the bioreactor was detached from the base, the stopcocks opened, and bubbles expelled. After inspection, the bioreactor was attached to the base and returned to its normal rotational speed. Approximately 90% of the media was exchanged after 5 days, and then exchanged daily for 13-16 more days. After 18-21 days in the bioreactor, the mature aggregates were transferred to a 50 ml conical centrifuge tube and washed three times with 1X HBSS.
METHODS
Aggregates were then transferred to 24-well tissue culture plates (50 ml per well, approximately 1 Â 10 5 cells ml À1 ) using a micropipettor fitted with a wide bore pipette tip. Some aggregates were transferred to 1 ml microcentrifuge tubes and characterized for markers of cellular differentiation as previously described (Nickerson et al. 2001; Honer zu Bentrup et al. 2006; Straub et al. 2007) . Trypan blue dye exclusion was performed to assess the viability of the cells prior to infection. Greater than 95% of the cells were viable after culture for 18-21 days. In addition, some aggregates were further characterized by examination of ultra-thin sections using transmission electron microscopy. Depending on the cell yield, three to four 24-well plates were produced from one bioreactor.
Norovirus stocks
Human norovirus stocks were obtained from several sources. 
Infectivity assays
For infectivity assays a 1:1,000 dilution of the viral stocks (and hNoV negative stool samples), prepared in sera-free MEM alpha, was used to infect the aggregates in the 24-well tissue culture plates. The predicted initial quantity of virions in these dilutions, determined by qRT-PCR, were as follows. For the two different genogroup I samples, the initial predicted titre added to each well was 802758 and 6,3907681 copies for samples 3-9 and 4-3, respectively. For the Genogroup II viruses, 386 had an initial predicted titre of 4177 copies and 1 G had a predicted titre of 529759 copies.
The total volume in each well was approximately 150 ml (100 ml of sample and 50 ml of cells). This volume was sufficient to just cover the cells and allow for maximal viral contact with the cell suspension. Plates were incubated for 1 h at 371C in a 5% CO 2 incubator. Plates were gently rocked every 15 minutes.
For the 1 h and all subsequent time points, wells were completely sampled, without replacement, at each time point.
For any given time point, some wells would be processed to assess viral RNA amplification and others for microscopic analysis. At 1 h post-infection, cells in all wells were overlaid with 1 ml of sterile sera-free MEM alpha. After overlaying the cells with media, wells designated as the 1 h post-infection time point were harvested using a micropipettor fitted with a wide bore pipette tip to maintain tissue integrity, and transferred to 1.5 ml microcentrifuge tubes. Cells were centrifuged at 1,500 Â g for 3 min and the supernatant was aspirated and 
Microscopic analysis of infection
Initial observation of the uninfected and infected tissue aggregates for cytopathic effect (CPE) was made using a Micromaster s inverted microscope with phase contrast infinity corrected optics (Westover Scientific, Mill Creek, WA).
Images were captured and saved as jpeg images using a Micron USB2 Camera and Software (Westover Scientific).
The tissue aggregates were examined for potential CPE before harvesting the cells for further examination by TEM (transmission electron microscopy) or qRT-PCR.
Transmission electron microscopy of tissue thin sections
Sub-cellular CPE was assessed by transmission electron microscopy using the methods described by Straub et al. (2007) . Ultra-thin sections (70 nm) were affixed on 100 mesh copper grids coated with forvar and carbon (Electron Microscopy Sciences (EMS), Hatfield, PA) and were poststained with 1% aqueous uranyl acetate (EMS) and 1%
Reynolds lead citrate (Reynolds 1963 ) before viewing on a Tecnai T-12 transmission electron microscope (FEI Co., Hillsboro, OR) operating at 120 kV with LaB filament.
Images were collected digitally using a 2 Â 2 K UltraScan 1000 charge-coupled device (Gatan Inc., Pleasanton, CA).
Immune electron microscopy
Immune electron microscopy (IEM) was performed on GI.1 infected (4-3) and uninfected tissues (4-1). For these experiments, IEM was performed on viruses that had been passaged through the 3-D Caco-2 cell cultures two times. After freeze thaw lysis and extraction with decafluoropentane, the titre measured by qRT-PCR for the infected tissues after passage was 1.01 Â 10 6 copies ml À1 . The primary antibody was a mouse monoclonal antibody to a peptide in the GI.1 capsid To ensure that viruses were cell-associated, harvested tissue aggregates were washed three times in sterile 1X PBS. Briefly, tissue aggregates, free of media, were resuspended in PBS, gently pelleted by centrifugation (1,500 Â g for 3 min) and the supernatant aspirated. This process was repeated two additional times. After the third wash, the supernatant was aspirated and the pellets were resuspended in 500 ml of 1X PBS. Viruses were released from the cells by freezing at À801C and thawing at room temperature. The crude lysate was extracted with an equal volume of Vertrel (decafluoropentane; Sigma, St Louis, MO) and the aqueous phase was recovered. Uninfected cells were processed in the same manner. The aqueous phase was then processed for IEM.
Processing of the EM grids consisted of a series of different buffer and antibody solutions arrayed on a hydrophobic piece of Parafilm (VWR), and all steps were performed at room temperature. After the TEM grids were exposed face down to drops of hNoV extracts for 10 min, they were processed by transfer to 100 ml drops of respective solutions by the following protocol: fixation in 2% paraformaldehyde in 1X PBS (EMS) for 15 min, three washes in 1X PBS (2 min each), 1% bovine serum albumin (BSA) in 1X PBS (3 min), blocking in 2% BSA (20 min), and a wash with 1% BSA (3 min). For grids receiving primary antibody, the optimal dilution was determined to be 1:100 in 1% BSA. For controls where primary antibody was omitted, grids were exposed to 1% BSA only. Primary antibody exposure (or mock) proceeded for 60 min. The grids were then washed three times in 1% BSA, exposed to secondary antibody (1:20 in 1% BSA, 60 min), washed three times in 1% BSA and then three times in 1X PBS. The grids were post-fixed in 2% glutaraldehyde in 1X PBS (EMS) for 5 min, finally washed three times in 1X PBS and three times in distilled water. Grids were counterstained with Nano-W (methylamine tungstate, Nanoprobes, Yaphank, NY) for 30 s, blotted dry and then imaged.
Nucleic acid extraction from stools and cells
To prepare stool samples and tissue aggregates for qRT-PCR analysis, materials were processed using Qiagen's RNEasy Plus kit (Qiagen, Valencia, CA). The protocol was modified to include the use of a QiaShredder column (Qiagen) and a genomic DNA removal column allowing total RNA to be analysed for virus or host RNA. Tissue aggregates (50 ml with some residual liquid) were suspended in 350 ml of buffer RLT containing 0.146% beta mercaptoethanol ( ME, 10 ml of a 14.6% solution added to each ml of buffer RLT) and vortexed until the microcarrier beads dissolved. The suspension was homogenized by passing it through a QiaShredder column (Qiagen). The filtrate was then added to the genomic DNA removal column. The filtrate was recovered, and the remainder of the procedure was followed according to manufacturer's instructions, exercising the following options. After the last wash with buffer RPE, the columns were transferred to clean collection tubes and centrifuged at 16,100 Â g for 1 min to ensure ethanol removal. The column was eluted with nuclease-free distilled water (2 Â 30 ml) yielding a final (Table 1) . Straub et al. (2007) , while the Genogroup II was based on sample VS122 (provided by C.P. Gerba from a previous study). PCR primers (Table 2) were designed to amplify a fragment that was slightly longer than the segment amplified by real-time PCR. Degenerate primers were used to generate the standards owing to the high level of sequence diversity in hNoV strains.
Quantitative reverse transcription PCR
Quantitative RT-PCR for Genogroup I and Genogroup II followed the protocol of Kageyama et al. (2003) , with the following modifications. Real-time PCR was performed on an ABI 7500 Fast Real-Time PCR System, but using a modified thermal cycling protocol (2 min at 501C for Uracil DNA Glycosylase digestion, 10 min at 951C, and then 45 cycles of denaturation for 15 s at 951C and primer annealing and extension for 1 min at 561C), and standards for Genogroup I and Genogroup II were generated from in vitro RNA transcripts as described above. 
RESULTS

Cytopathic effects from human norovirus infection
Our first experiment was conducted using the 3-D Caco-2 cells along with hNoV negative (4-1) and hNoV positive stool samples (Sample 4-3, GI.1) from the Emory human challenge trial to determine: 1) if there was a pathological difference that could be readily observed between non-infectious vs.
infectious stools; and 2) if stool samples, even diluted in sera-free media, had toxic effects for these cells. Figure 2 shows that there were little, if any, pathological differences between the cells regardless of the time point when these tissue aggregates were examined using an inverted micro-
scope. Figure 2(h) is from sample 4-3 after 72 h post-infection
and showed some suspect cytopathic effect (CPE). This was, however, an exception rather than the rule for the infected samples, and similar sample characteristics were also occasionally observed in uninfected controls or negative stool sample challenge at any time point. In subsequent challenges with the additional GI.1 patient sample (3-9), and GII.4 samples, no detectable CPE was observed when these aggregates were examined using the inverted microscope at 100-200 Â magnification. These initial results show that toxicity due to components in the stool, regardless of whether it is free from virus or contains virus, is not a factor for infectivity studies using 3-D Caco-2 cells and the stool samples selected for this study.
These same samples were analysed by TEM and the results were dramatically different. Figure 3 Immune electron microscopy reveals antibody localization IEM was performed on hNoV infected (GI.1) and uninfected tissue culture. In this study, the viruses had been passaged through cell culture twice. When qRT-PCR was performed after the lysed cells had been extracted with decafluoropentane, the measured titre of hNoV was 1.01 Â 10 6 copies ml À1 . Even with organic extraction, there was a fair amount of cellular debris that had partitioned into the aqueous phase, and this was the likely cause of being unable to visualize virions. Nevertheless, despite not being able to clearly discern viral structure, Figure 4 shows localization of the 6 nm gold-labelled secondary antibodies for nor- Table 4 .
and controls with uninfected cells but with both primary and secondary antibodies added, did not reveal any localization of the gold secondary antibodies. The inability to visualize viral particles in positive specimens is not without precedence. In the human biopsy studies pathology of the cells was observed but viral particles were not (Schreiber et al. 1973; Dolin et al. 1975; Troeger et al. 2009 were observed in these cells (Cheetham et al. 2006 (Cheetham et al. , 2007 .
Immune localization taken together with increases in viral copies measured by qRT-PCR provides evidence consistent with norovirus infectivity in cell culture.
Viral copy number increases significantly in infected 3-D Caco-2 cells
The realization that cells within the tissue aggregates were possibly infected with hNoV, and that these same cells remained attached to the tissue structure on the collagen microspheres led us to focus our investigation on virus interaction with these cells. Table 3 24 h samples for 4-1 were 0.9 and 1.6 ng ml À1 , respectively.
These concentrations are very similar for cells that were not exposed to faecal material over 72 h (Table 1) . However, the total RNA concentration for the 4-1 48 h sample was 108 ng ml À1 . This observation was consistent with increases in total RNA concentration for cells infected with norovirus over 72 h (Table 1) original stool samples revealed that sample 3-9 had a qRT PCR titre that was approximately 1 Log 10 less than sample 4-3 (802758 copies and 6,3907681 copies for 3-9 and 4-3, respectively). In this case (sample 3-9), qRT-PCR was negative at 1 h and 48 h post-infection, indicating that the viral titre was below the limit of detection of our assay. There was, however, a significant increase in viral copy number as the infection proceeded to 72 h and 1 week post-infection.
Norovirus was detected in sample 4-3 at all time points. A decrease in Ct of approximately 3.3-3.7 cycles (depending on amplification efficiency) represents a 1 Log 10 increase in viral copy number. Thus for samples 3-9 and 4-3, we observed an approximate 2-3 Log 10 increase in viral titre for these infectivity trials (Tables 3 and 4) .
From the original titres in our GII.4 stool samples we estimated that the viral copy numbers delivered to the cells for samples 386 and 1 G were approximately 40 copies and 500 copies per well, respectively. From the data for sample 1 G in Table 5 , we estimate that approximately 10% of our expected viral dose attached to, and infected the 3-D 
DISCUSSION An infectivity assay vs. a stable replication system
There has been a long-standing need to be able to assess potential infectivity of human noroviruses recovered from water, food and environmental surfaces that have been contaminated in various outbreak settings. Our results for infection of the 3-D Caco-2 cells with human norovirus indicate that: 1) cellular pathology (namely, the loss or shortening of apical microvilli) is consistent with observations in previous in vivo studies (Schreiber et al. 1973; Dolin et al. 1975; Cheetham et al. 2006; Souza et al. 2008; Troeger et al. 2009 ); and 2) viral RNA copy number is significantly increasing (4 2 Log 10 ) as the course of the infection proceeds. For the results presented here, we are confident that we have developed an infectivity assay that could be used by laboratories to assess norovirus infectivity when these viruses are recovered from environmental samples. It is important to point out that this infectivity assay may not be a true replication system. Viral RNA could be amplifying, but not necessarily producing infectious progeny virions. This may provide a partial explanation of why we were unable to visualize new virions despite antibody localization (Figure 4 ). However given that the antibody localization studies were based on passaged viruses, there is a possibility that we have both an infectivity assay and replication system. For virion visualization, it is likely that more sample clean-up (e.g. purification by ultracentrifugation of the crude lysate through a CsCl 2 or sucrose gradients) will be required.
If the norovirus assay is only an infectivity assay, it would be analogous to the cell-culture infectivity assay for the protozoan Cryptosporidium parvum (Rochelle et al. 2002) . Nonetheless, the assay described here would still be appropriate to answer the problem of determining infectivity of noroviruses isolated from environmental settings. 2) mixed Genogroups of hNoV could be recovered; Positive secretor status appears to be the critical factor governing human susceptibility to norovirus infection (Thorven et al. 2005) . If secretor status alone is important, there are a number of human cell lines that express the correct histoblood group antigens on their cell surfaces, including Huh-7 and Caco-2 (Guix et al. 2007) , and even INT 407 (Straub et al. 2007 ). However, even with over-expression of the FUT2 gene, which governs secretor status, this factor alone led to greater attachment, but not entry of progeny noroviruses into the cells to complete a subsequent round of infection (Guix et al. 2007 ).
In our continued research, it is our hypothesis that the common denominator that leads to successful norovirus infection of the 3-D Caco-2 cells is clonal populations of cells that consistently express brush borders. This is the population we are working with and report in this paper. If this hypothesis is correct, reproducibility of the norovirus assay both within a single laboratory and across independent laboratories could be problematic, given the heterogeneity of this cell line (Peterson & Mooseker 1992) . 
STATEMENT OF HUMAN SUBJECTS PROTECTION AND ACKNOWLEDGEMENTS
Prior to receiving faecal samples from Emory University and the University of Arizona, study plans were reviewed and approved by the PNNL Institutional Review Board for Human Subjects Research, and were compliant with United
States NIH regulations regarding human subjects research.
Any potential patient identifying information, dates and location were removed prior to samples being sent to PNNL. 
